๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease

โœ Scribed by John Kushleika; Dr. Harvey Checkoway; James S. Woods; Jai-Dong Moon; Terri Smith-Weller; Gary M. Franklin; Philip D. Swanson

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
356 KB
Volume
39
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Selegiline and mortality in Parkinson's
Selegiline and mortality in Parkinson's disease
โœ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 489 KB ๐Ÿ‘ 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran